氢氧化钙与N-乙酰半胱氨酸对根尖周炎消退素E1和D2水平的影响
本研究纳入36颗原发性根管感染伴根尖周炎的单根牙,随机分为氢氧化钙+生理盐水组、氢氧化钙+2%氯己定凝胶组和N-乙酰半胱氨酸组,检测根尖周间质液中消退素E1和D2在用药前及用药14天后的水平。结果显示两组消退素在所有样本中均可检出,氢氧化钙未升高消退素水平,而N-乙酰半胱氨酸显著升高消退素E1和D2水平。
要点
- 根尖周炎患牙根尖周组织中可检出消退素E1和D2。
- 氢氧化钙根管内封药未升高消退素E1和D2水平。
- N-乙酰半胱氨酸封药14天显著升高消退素E1和D2水平。
核心结论
- 氢氧化钙根管内封药不增加根尖周炎消退素E1和D2水平,而N-乙酰半胱氨酸封药14天显著升高两者水平。
研究设计与样本
- 随机对照研究,纳入36颗单根牙的原发性根管感染伴根尖周炎患牙,随机分为氢氧化钙+生理盐水组(n=12)、氢氧化钙+2%氯己定凝胶组(n=12)和N-乙酰半胱氨酸组(n=12)。
- 在封药前(S1)和封药14天后(S2)采集根尖周间质液,采用酶联免疫吸附试验检测消退素E1和D2。
- 统计分析采用配对t检验、Wilcoxon检验和Kruskal-Wallis检验,后行Dunn事后检验,显著性水平为5%。
主要发现
- 消退素E1和D2在S1和S2的36/36样本中均被检出(100%)。
- 氢氧化钙封药未升高消退素E1或D2水平(两者P > 0.05)。
- N-乙酰半胱氨酸封药14天后显著升高消退素E1和D2水平(P < 0.05)。
临床怎么用
- 对于原发性根管感染伴根尖周炎,N-乙酰半胱氨酸根管内封药可能通过升高消退素E1和D2促进炎症消退。
- 氢氧化钙封药未必通过消退素途径发挥抗炎作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To investigate the presence of resolvins E1 (RvE1) and D2 (RvD2) in teeth with primary endodontic infections and apical periodontitis, and to assess the influence of calcium hydroxide medication [Ca(OH)2 ], in association with 2% chlorhexidine gel (2% CHX gel), and N-acetylcysteine (NAC) on the levels of RvE1 and RvD2 in periapical tissues. METHODOLOGY: Thirty-six single-rooted teeth with primary endodontic infections and apical periodontitis were selected and randomly divided into three groups according to the medication: [Ca(OH)2 ] + saline solution (SSL) [Ca(OH)2 + SSL group] (n = 12), Ca(OH)2 + 2% chlorhexidine gel [Ca(OH)2 + 2% CHX gel group] (n = 12) and NAC [NAC group] (n = 12). Samples were collected from the periapical interstitial fluid at two different sampling times: before (S1) and after 14 days of intracanal medications (S2). Resolvins were measured using the enzyme-linked immunosorbent assay. Data were analysed using paired t-test, Wilcoxon test and Kruskal-Wallis test, followed by Dunn's post hoc test; all statistical tests were performed at a significance level of 5%. RESULTS: RvE1 and RvD2 were detected in 100% of the samples (36/36) at S1 and S2. Ca(OH)2 medication did not increase the levels of RvE1 or RvD2 (both P > 0.05); however, NAC significantly increased the levels of RvE1 and RvD2 after 14 days of treatment (P < 0.05). CONCLUSIONS: RvE1 and RvD2 were detected in periapical tissues from teeth with root canal infections. Moreover, calcium hydroxide medication did not increase the levels of resolvins in apical periodontitis. In contrast, the use of NAC intracanal medication significantly increased the levels of RvE1 and RvD2 after 14 days of treatment.
引用
- Corazza BJM, Martinho FC, Khoury RD, et al. Clinical influence of calcium hydroxide and N-acetylcysteine on the levels of resolvins E1 and D2 in apical periodontitis. Int Endod J. 2020. PMID: 32896000. doi:10.1111/iej.13403
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。